A SINGLE CENTER, OPEN LABEL, FIXED SEQUENCE, TWO-PERIOD STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSE CARBAMAZEPINE ON SINGLE DOSE PHARMACOKINETICS OF RO4917838 IN HEALTHY MALE VOLUNTEERS.
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2016
At a glance
- Drugs Bitopertin (Primary) ; Carbamazepine
- Indications Epilepsy; Schizophrenia and disorders with psychotic features
- Focus Pharmacokinetics
- Sponsors Roche
- 01 Mar 2012 Actual end date changed from Nov 2011 to Mar 2012 as reported by ClinicalTrials.gov.
- 19 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2011 New trial record